NanosVet sells $8.3M to build fast-dissolving pet medicine
NanosVet has 17 investors behind an $8.6M offering, while its catalog lists one product for sale.
By RuntimeWire Staff · Published
Primary source: SEC
Why it matters
The $8.3M gives Andrew Green room to turn one pet-wellness strip into a veterinary drug-delivery platform. Clinical evidence and repeatable manufacturing will determine whether NanoMelt earns that label.

Andrew Green, founder and CEO of NanosVet, has sold $8.3 million of securities to finance a pet-health platform built around fast-dissolving oral strips, according to a Form D filed with the SEC.…